Viking Therapeutics (VKTX) Misses Q2 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q2 EPS of ($0.21), $0.01 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Humana reaffirms 2026 earnings guidance ahead of investor meetings